|
|
|
|
|
02.09.26 - 12:36
|
Cresco Labs Acquires Nine Pennsylvania Dispensaries in Accretive Transaction to Strengthen Market Leadership (Business Wire)
|
|
|
CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”) today announced the closing of its acquisition of 100% of the outstanding equity interests in PharmaCann Penn, LLC (“PharmaCann”) for an aggregate consideration of US$50 million (the “Transaction”). The Transaction consists of nine operational retail medical marijuana dispensaries in Pennsylvania, advancing Cresco's leadership position in the second-largest medical marijuana market, which generated more than US$1.1 billion1 in annual sales last year.“We are focused on deploying capital into opportunities that strengthen our competitive position and generate attractive long-term returns. This transaction expands our retail footprint in a core market through a highly strategic acquisition while creating additional opportunities to leverage our existing infrastructure,” said Charlie Bachtell, CEO of Cresco Labs. “Pennsylvania is one of our core markets, where scale and vertic...
|
|
|
|
|
|
|
|
|
06.08.26 - 12:36
|
Cresco Labs Reports Second Quarter 2026 Financial Results; Delivers $173 Million in Revenue and $40 Million in Adjusted EBITDA (Business Wire)
|
|
|
CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America's most popular brands and the operator of Sunnyside dispensaries, today released its financial and operating results for the second quarter ended June 30, 2026. All financial information presented in this release is reported in accordance with U.S. GAAP and in U.S. dollars, unless otherwise indicated, and is available on the Company's investor website, here.
Second Quarter 2026 Highlights
Second quarter revenue of $173 million.
Gross profit of $87 million. Adjusted gross profit1 of $89 million; and an Adjusted gross margin1 of 51.6%.
SG&A of $63 million or 36.5% of revenue. Adjusted SG&A of $55 million or 32.0%. The difference between SG&A and Adjusted SG&A is primarily attributable to one-time and non-recurring costs associated with M&A, uplisting preparedness and federal reform.
Net income of $15 million.
S...
|
|
|
13.07.26 - 12:36
|
Cresco Labs to Report Second Quarter 2026 Financial Results on August 6, 2026 (Business Wire)
|
|
|
CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America's most popular brands and the operator of Sunnyside dispensaries, today announced it will report financial results for the quarter ended June 30th, 2026 on Thursday, August 6, 2026 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights.
Event: Cresco Labs Second Quarter 2026 Earnings Conference Call
Date: Thursday, August 6, 2026
Time: 8:30 am ET
Webcast: LINK
Archived access to the webcast will be available for one year on the Cresco Labs investor relations website.
About Cresco Labs Inc.
Cresco Labs' mission is to normalize and professionalize the cannabis industry through a CPG approach to building national brands and a customer-focused retail experience, while acting as a steward for the industry on legislative ...
|
|
|
08.06.26 - 12:03
|
Cresco Labs Closes US$50 Million Revolving Credit Facility with Needham Bank (Business Wire)
|
|
|
Access to conventional commercial bank financing enhances financial flexibility and supports Cresco Labs' disciplined growth and consolidation strategy.CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”) today announced the closing of a credit agreement with Needham Bank, a Massachusetts-based commercial bank, providing the Company with a US$50 million revolving credit facility (the “Facility”).
For Cresco Labs and the broader cannabis sector, capital has historically come from private credit at elevated rates. The Facility reflects the continued maturation of the industry, expanding access to more efficient sources of capital and further normalizing capital access for leading operators.
Borrowings under the Facility will be available to fund growth initiatives, acquisitions and general corporate purposes. As a source of non-dilutive capital, the Facility enhances Cresco's ability to pursue strategic opportunities that strengthen th...
|
|
|
|
|
|
|
|
|
08.05.26 - 12:36
|
Cresco Labs Reports First Quarter 2026 Financial Results, Advances Multiple Growth Initiatives (Business Wire)
|
|
|
CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America's most popular brands and the operator of Sunnyside dispensaries, today released its financial and operating results for the first quarter ended March 31, 2026. All financial information presented in this release is reported in accordance with U.S. GAAP and in U.S. dollars, unless otherwise indicated, and is available on the Company's investor website, here.
First Quarter 2026 Highlights
First quarter revenue of $151 million.
Gross profit of $75 million. Adjusted gross profit1 of $77 million; and an Adjusted gross margin1 of 50.7%.
SG&A of $54 million or 36.0% of revenue. Adjusted SG&A of $51 million or 33.7%.
Net loss of $17 million.
First quarter Adjusted EBITDA1 of $33 million and Adjusted EBITDA margin1 of 21.7%.
Retained the No. 1 share position in multiple billion dollar markets.2
Subsequent to Quarter ...
|
|
|
23.04.26 - 12:33
|
Cresco Labs to Report First Quarter 2026 Financial Results on May 8, 2026 (Business Wire)
|
|
|
CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America's most popular brands and the operator of Sunnyside dispensaries, today announced it will report financial results for the quarter ended March 31st, 2026 on Friday, May 8, 2026 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights.
Event: Cresco Labs First Quarter 2026 Earnings Conference Call
Date: Friday, May 8, 2026
Time: 8:30 am ET
Webcast: LINK
Archived access to the webcast will be available for one year on the Cresco Labs investor relations website.
About Cresco Labs Inc.
Cresco Labs' mission is to normalize and professionalize the cannabis industry through a CPG approach to building national brands and a customer-focused retail experience, while acting as a steward for the industry on legislative and regula...
|
|
|
26.03.26 - 18:54
|
CANNABIS TEAMSTERS WIN STRIKE AT CRESCO LABS (PR Newswire)
|
|
|
Workers Secure Better Wages, Health Care, and Improved Working Conditions WYOMISSING, Pa., March 26, 2026 /PRNewswire/ -- After 20 days on strike, Teamsters Local 429 members at Sunnyside Dispensary have secured a new contract. Sunnyside is a subsidiary of Cresco Labs, a publicly traded......
|
|
|
|
|
|
|
05.03.26 - 12:33
|
Cresco Labs Delivers Q4 2025 Revenue of $162 Million and Sequential Margin Improvement (Business Wire)
|
|
|
CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America's most popular brands and the operator of Sunnyside dispensaries, today released its financial and operating results for the fourth quarter ended and year ended December 31, 2025. All financial information presented in this release is reported in accordance with U.S. GAAP and in U.S. dollars, unless otherwise indicated, and is available on the Company's investor website, here.
Fiscal Year 2025 Highlights
Revenue of $656 million. Operating cash flow of $73 million and Free Cash Flow1 of $38 million.
Gross profit of $325 million. Adjusted gross profit1 of $329 million; and an Adjusted gross margin1 of 50.2%.
SG&A of $218 million. Reduced Adjusted SG&A1 by 5.7% year-over-year to $200 million, or 30.4%.
Net loss of $140 million, which includes one-time, non-cash charges of $105 million related to the Company's i...
|
|
|
26.02.26 - 22:06
|
CANNABIS TEAMSTERS AT CRESCO LABS GO ON STRIKE (PR Newswire)
|
|
|
Workers Demand Fair Wages, Stable Hours, and Respect WYOMISSING, Pa., Feb. 26, 2026 /PRNewswire/ -- Teamsters at the Sunnyside dispensary in Wyomissing, Pennsylvania voted unanimously to authorize a strike after the company failed to present a contract that fairly compensates its workers.......
|
|
|
23.02.26 - 12:31
|
Cresco Labs to Report Fourth Quarter 2025 Financial Results on March 5, 2026 (Business Wire)
|
|
|
CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America's most popular brands and the operator of Sunnyside dispensaries, today announced it will report financial results for the full year and quarter ended December 31st, 2025 on Thursday, March 5, 2026 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights.
Event: Cresco Labs Fourth Quarter 2025 Earnings Conference Call
Date: Thursday, March 5, 2026
Time: 8:30 am ET
Webcast: LINKConference Call Registration: LINKDial-in: 1-833-470-1428 (US Toll Free), 1-646-844-6383 (US Local)
Access Code: 152399
Archived access to the webcast will be available for one year on the Cresco Labs investor relations website.
About Cresco Labs Inc.
Cresco Labs' mission is to normalize and professionalize the cannabis industry through a CPG ap...
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
